Sanofi Seeks COVID Vaccine Approval After Delays
French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.The two drugmakers said they will "seek regulatory authorisation" for their vaccine in the United States (US) and the European Union (EU) following phase 3 trials involving thousands of people.The trials indicated that the vaccine was 100 percent effective against severe COV